Recently, Shenzhen Beike Biotechnology Co., Ltd. donated RMB 500,000 to the Wang Zhengguo Trauma Medical Development Foundation, actively fulfilling the company’s social responsibilities and demonstrating the company’s social responsibility. Academician Wang Zhengguo, founder of the Wang Zhengguo Trauma Medicine Development Foundation, and Dr. Hu Junyuan, chairman of Beike Biotech, signed a donation cooperation agreement on behalf of both parties. This donation will be used for Support the foundation to cultivate trauma medical research talents, carry out scientific research in trauma medicine, engage in trauma treatment public welfare activities, and promote the development of trauma medicine and trauma treatment systems and scientific research and education in my country.
Wang Zhengguo Trauma Medicine Development Foundation was founded in 2014. The foundation adheres to the purpose of promoting academician Wang Zhengguo’s noble medical ethics and rigorous scholarship, promoting the development of trauma medicine, rewarding medical technicians who have made outstanding contributions to trauma medicine, and providing funding for trauma medicine activities in primary health care. It focuses on supporting trauma scientific research and carrying out trauma public welfare activities, and has played a positive role in promoting the healthy development of the trauma field. It is a public welfare organization with both reputation and influence in the industry.
Academician Wang Zhengguo, founder of the foundation, expressed his appreciation and gratitude to Beike Biotech for its generous donation, and said that death caused by trauma ranks fifth among the total causes of death among residents in my country. Counties in our country occupy 90% of the land area, and most of the first trauma scenes are in the vast areas of counties. In these areas, there are four major lags in trauma care: lagging concepts, lagging models, lagging processes, and lagging capabilities. It is hoped that in the future, the foundation can work hand in hand with Beike Biotech to carry out more and deeper cooperation in the field of trauma treatment in my country, especially to improve the quality development of medical standards in backward areas, improve the level of grassroots treatment, and strive to contribute to “Healthy China”.
Dr. Hu Junyuan, chairman of Beike Biotech, also introduced that since its establishment, Beike Biotech has been adhering to the corporate vision of becoming a leading company in promoting the clinical transformation of biotherapeutic technologies and making unremitting efforts to improve human health, and has regarded fulfilling social responsibilities as the company’s top priority. A trickle can become a river, and a single spark can start a prairie fire. This donation activity by Beike Biotech is a concrete measure by Beike Biotech to fulfill the original intention of the company. I hope to work together with the Wang Zhengguo Trauma Medicine Development Foundation in the future to allow more trauma people to receive treatment, promote the social popularization of trauma and accidental injury prevention and control for all, and further promote the sustainable development of trauma medicine in my country.